Literature DB >> 1669521

PCBs, DDE, and child development at 18 and 24 months.

W J Rogan1, B C Gladen.   

Abstract

To determine whether perinatal exposure to "background" levels of polychlorinated biphenyls (PCBs) or dichlorodiphenyldichloroethene (DDE) affected child development, we followed a cohort of children through the age of 2 years; 676 were tested at 18 months and 670 at 24 months with the Bayley Scales. Transplacental and cumulative exposures from breast milk to both chemicals were estimated for each child from analyses of breast milk and other samples. Bayley testing was done without knowing the chemical levels. At 18 and 24 months, adjusted scores on the psychomotor scales were 4 to 9 points lower among children in the top fifth percentile of transplacental PCB exposure, significantly so at 24 months. There were no consistent effects apparent from exposure to PCBs through breast milk, nor from DDE exposure. We conclude that there is a small delay in motor maturation attributable to transplacental exposure to PCBs that is still detectable at 24 months. There is no evidence of an effect from the larger but later exposure through breast milk, although effects may emerge as the children age.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1669521     DOI: 10.1016/1047-2797(91)90010-a

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  53 in total

Review 1.  Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review.

Authors:  N Ribas-Fitó; M Sala; M Kogevinas; J Sunyer
Journal:  J Epidemiol Community Health       Date:  2001-08       Impact factor: 3.710

2.  A partial linear model in the outcome-dependent sampling setting to evaluate the effect of prenatal PCB exposure on cognitive function in children.

Authors:  Haibo Zhou; Guoyou Qin; Matthew P Longnecker
Journal:  Biometrics       Date:  2010-10-29       Impact factor: 2.571

3.  Association of serum concentrations of persistent organic pollutants with the prevalence of learning disability and attention deficit disorder.

Authors:  Duk-Hee Lee; David R Jacobs; Miquel Porta
Journal:  J Epidemiol Community Health       Date:  2007-07       Impact factor: 3.710

Review 4.  Breast-feeding in a polluted world: uncertain risks, clear benefits.

Authors:  J W Frank; J Newman
Journal:  CMAJ       Date:  1993-07-01       Impact factor: 8.262

Review 5.  Endocrine-disrupting actions of PCBs on brain development and social and reproductive behaviors.

Authors:  Margaret R Bell
Journal:  Curr Opin Pharmacol       Date:  2014-10-10       Impact factor: 5.547

6.  Cognitive functioning in 8- to 18-month-old drug-exposed infants.

Authors:  S M Alessandri; M Bendersky; M Lewis
Journal:  Dev Psychol       Date:  1998-05

7.  Altered fine motor function at school age in Inuit children exposed to PCBs, methylmercury, and lead.

Authors:  Olivier Boucher; Gina Muckle; Pierre Ayotte; Eric Dewailly; Sandra W Jacobson; Joseph L Jacobson
Journal:  Environ Int       Date:  2016-08-27       Impact factor: 9.621

8.  PCBs and ADHD in Mohawk adolescents.

Authors:  Joan Newman; Bita Behforooz; Amy G Khuzwayo; Mia V Gallo; Lawrence M Schell
Journal:  Neurotoxicol Teratol       Date:  2014-01-21       Impact factor: 3.763

Review 9.  The Pine River statement: human health consequences of DDT use.

Authors:  Brenda Eskenazi; Jonathan Chevrier; Lisa Goldman Rosas; Henry A Anderson; Maria S Bornman; Henk Bouwman; Aimin Chen; Barbara A Cohn; Christiaan de Jager; Diane S Henshel; Felicia Leipzig; John S Leipzig; Edward C Lorenz; Suzanne M Snedeker; Darwin Stapleton
Journal:  Environ Health Perspect       Date:  2009-05-04       Impact factor: 9.031

10.  Exposure to hydroxylated polychlorinated biphenyls (OH-PCBs) in the prenatal period and subsequent neurodevelopment in eastern Slovakia.

Authors:  Hye-Youn Park; June-Soo Park; Eva Sovcikova; Anton Kocan; Linda Linderholm; Ake Bergman; Tomas Trnovec; Irva Hertz-Picciotto
Journal:  Environ Health Perspect       Date:  2009-05-20       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.